Evidence map›Paper›PMID 41888813›Full record

ArticleBMC endocrine disorders2026

Current status of hypothyroidism control in Guangzhou area, China: a cross-sectional survey.

Bo Chen, Shaobo Wang, Yali Huang, Deqing Liu, Runjie Chen, Hua Zhang, Wenying Wang, Qian Zhou, Liuqi Lie, Jianmin Ran and 1 more

Abstract read
In one paragraph

Article in BMC endocrine disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Bo Chen *Department of Endocrinology, Department of diabetes and obesity reversal research center, The Affiliated Guangdong Second Provincial General Hospital of Jinan University, 466 Xingang Middle Road, Haizhu District, Guangzhou, 510317, China.
Shaobo Wang *Department of Endocrinology, Houjie hospital and Clinical College of Guangdong Medical University, Dongguan, 523945, China.
Yali Huang *Department of Endocrinology, Department of diabetes and obesity reversal research center, The Affiliated Guangdong Second Provincial General Hospital of Jinan University, 466 Xingang Middle Road, Haizhu District, Guangzhou, 510317, China.
Deqing LiuDepartment of Tuberculosis Internal Medicine, Guangzhou Key Laboratory of Tuberculosis Research, State Key Laboratory of Respiratory Disease, Guangzhou Chest Hospital, Guangzhou, 510095, China.
Runjie ChenZhongshan City People's Hospital, Zhongshan, 528400, China.
Hua ZhangDepartment of Endocrinology and Metabolism, Zhujiang Hospital of Southern Medical University, Guangzhou, 510315, China.
Wenying WangEndocrinology Department, The Affiliated TCM Hospital of Guangzhou Medical University, Guangzhou, 510310, China.
Qian ZhouDepartment of Metabolism and Endocrinology, Guangzhou First People's Hospital, Guangzhou, 510312, China.
Liuqi LieDepartment of Endocrinology, Department of diabetes and obesity reversal research center, The Affiliated Guangdong Second Provincial General Hospital of Jinan University, 466 Xingang Middle Road, Haizhu District, Guangzhou, 510317, China.
Jianmin RanEndocrinology Department, Institute of Diseases-Oriented Nutrition Research, Guangzhou Red Cross Hospital, Medical College of Jinan University, Tongfu Middle Road, Haizhu District, Guangzhou, 510220, China. ran_jianmin@ext.jnu.edu.cn.
Gugen XuDepartment of Endocrinology, Department of diabetes and obesity reversal research center, The Affiliated Guangdong Second Provincial General Hospital of Jinan University, 466 Xingang Middle Road, Haizhu District, Guangzhou, 510317, China. gugenxu@163.com.

Funding

Guangzhou Science and Technology Plan Project 202201020567The first batch of 3D printing research projects at the Second People's Hospital of Guangdong Province in 2020 3D-D2020022The Scientific and Technological Projects of Dongguan city, Guangdong province, China 20221800905852
6 · The paper itself

Abstract

backgroundHypothyroidism is a significantly harmful condition that severely affects work and daily life. Currently, there is a lack of large-scale investigations into the treatment control status in China. This study aimed to combine a large sample of patients with hypothyroidism in the Guangzhou area to analyze hypothyroidism control rates.

methodsA cross-sectional survey was conducted at six tertiary A-grade hospitals in Guangzhou city. On-site questionnaire surveys were administered to randomly sampled outpatients with hypothyroidism (n = 1516) to collect cross-sectional data. The collected data were analyzed to summarize the current status of hypothyroidism control, the composition of hypothyroidism etiology, complications, and their correlation with hypothyroidism control rates in Guangzhou.

resultsThe overall control rate of patients with hypothyroidism (with TSH level < 4 mU/L as the standard) was 59.4% (49.2% in males and 61.2% in females). There was a significant correlation between TSH control rate and sex and education. In addition, the TSH control rate after treatment was higher in those aged < 35 years and during the mid-term of pregnancy in pregnant women with hypothyroidism. The control rate of TSH was closely associated with abnormal liver function, menstrual disorders, dysmenorrhea, and sleep disorders. Finally, a history of thyroid surgery, type of thyroid surgery, and presence of Hashimoto’s thyroiditis were correlated with the control rate of TSH.

conclusionThe control rate in patients with hypothyroidism was relatively low in Guangzhou area. Patients with hypothyroidism and clinical characteristics closely associated with poor hypothyroidism control should receive special attention. CLINICAL TRIAL NUMBER: Not applicable.

Indexed as

HypothyroidismThyrotropinThyroxineAdultChinaCross-Sectional StudiesFemaleFollow-Up StudiesHumansMaleMiddle AgedPregnancyPrognosisSurveys and QuestionnairesYoung AdultThyrotropinThyroxineFree thyroxineFree triiodothyronineHypothyroidismThyroid-stimulating hormoneTotal thyroxineTotal triiodothyronine

Identifiers

PMID41888813
PMCPMC13137615

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.